12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Genisphere, Lankenau Institute deal

Genisphere and the non-profit added the development of nanotherapeutics targeting cancer and ophthalmic diseases to an ongoing deal. The...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >